Correlation of the Quality of Antibiotic Usage by Utilising Gyssens Flow and The Success of Treatment in Negative Gram MDR Sepsis in Tertiary Hospital

Authors

Soroy Lardo, 1. Divisi Tropik dan Penyakit Infeksi Departemen Penyakit Dalam RSPAD Gatot Soebroto, Jakarta 2. Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/RSUPN dr. Cipto Mangunkusumo, Jakarta
Lie Khie Chen, Divisi Tropik dan Penyakit Infeksi, Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/RSUPN dr. Cipto Mangunkusumo, JakartaFollow
Widayat Djoko Santoso, Divisi Tropik dan Penyakit Infeksi, Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/RSUPN dr. Cipto Mangunkusumo, Jakarta
Cleopas Martin Rumende, Unit Epidemiologi Klinik, Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia/RSUPN dr. Cipto Mangunkusumo, Jakarta

Abstract

Introduction. Multi Drug Resistance (MDR) antibiotics have become a global health threat to the community. The use of appropriate antibiotics makes preventive and curative measures very important for the success of overcoming MDR and intervening the complexity of resistance, at least slowing the rate of occurrence of MDR. This study aimed to identify the difference in the quality of antibiotic use quality of use using gyssens flowchart and the success in sepsis patients’ treatment due to gram-negative MDR bacteria with non-MDR bacterial infections in tertiary hospitals. Methods. A retrospective cohort study was conducted using secondary data from patient with age more or equal than 18 years who were hospitalized in inpatient unit or ICU in Indonesia Army Central Hospital Gatot Soebroto from 2017-2019. Both the MDR and non-MDR gram-negative inclusion groups were assessed for the quality of antibiotic using the Gyssen flowchart. Results. There was a significant difference between antibiotic quality on gram negative MDR bacteria and non-MDR (20.6% vs. 13.6%; RR 1.517 (CI 95% 1.1 – 2.1); p value = 0.015) which showed that gram-negative MDR experienced 1.517 times better quality than non-MDR. This study also found that there was a significant difference between therapeutic success on gram negative MDR bacteria and non-MDR (57.4% vs. 39.1%; RR 1,431 (CI 95% 1.0 – 2.1); p value = 0.02). Conclusions. There is a better quality on the utilization of antibiotics with Gyssens index patients resulted from MDR negative gram bacterial infection in comparison to non-MDR in tertiary hospital. There is also a better success in treating the sepsis patient with MDR negative gram bacterial infection in comparison with non-MDR.

References

1. Campbell J, Sprenger M. WHO competency framework for health workers’ education and training on antimicrobial resistance. World Health Organization. Geneva: WHO; 2018. 2. Karam G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136 3. Center for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2013. 4. Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259–72. 5. Clermont G, Lidicker J, Angus DC, Pinsky MR, Carcillo J, LindeZwirble WT. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2003;29(7):1303–10. 6. Tambajong R, Lalenoh DC, Kumaat L. Profil penderita sepsis di ICU RSUP Prof. Dr. R.D. Kandou Manado. J e-Clinic. 2015;4(1):452-7. 7. Sarada D. Efek kortikosteroid dosis rendah terhadap perbaikan klinis pasien sepsis dengan menggunakan evaluasi skor APACHE II T [Tesis]. Surakarta: Fakultas Kedokteran Universitas Sebelas Maret; 2009. 8. Susanti F, Dewi AD, Setyawati S. Hubungan procalcitonin dengan hasil positif kultur bakteri pada pasien sepsis [Tesis]. Yogyakarta: Fakultas Kedokteran Universitas Gadjah Mada; 2015. 9. Serpa-Pinto L, Cardoso T. Risk factors for multi-resistant organisms in sepsis. Crit Care. 2014;18(Suppl 1):342. 10. Oktavina MN. Analisa kualitatif pada penggunaan antibiotik. Fatmawati Hosp J. 2016;1(4):1-5. 11. Zilberberg MD, Shorr AF, Micek ST, Guillamet CV, Kollef MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18:596. 12. Howell MD, Talmor, Schuetz P,Hunziker S, Jone AE, Shapiro NI. Proof of principle: the predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39:322-7. 13. Kumalo A, Kassa T, Daka D, Henok A. Bacterial profile of adult sepsis and their antimicrobial susceptibility pattern at Jimma University Specialized Hospital, South West Ethiopia. Health Sci J. 2016;10(2):3. 14. Pradipta IS, Sodik DC, Lestari K, Parwati I, Halimah E, Diantini A, Abdulah R. Antibiotic resistance in sepsis patients: evaluation and recommedation of antibiotic use. North Am J Med Sci. 2013;5(6):342-52. 15. Pulia MS, Redwood, Sharp B. Antimicrobial stewardship in the management of sepsis. Emerg Med Clin N Am. 2017;35:199–217. 16. Yokota PK, Marra AR, Martiona MDV, Victor ES, Dura M, Edmond MB, Santos OF. Impact of appropiate antimicrobial therapy for patients with severe sepsis and septic shock- a quality improvement study. Plos One. 2014;9(11):e104475. 17. Allison MG, Heil EL, Hayes BD. Appropiate Antibiotic Therapy. Emerg Med Clin North Am. 2017;35:25–42.

Recommended Citation

Lardo, Soroy; Chen, Lie Khie; Santoso, Widayat Djoko; and Rumende, Cleopas Martin (2020) "Correlation of the Quality of Antibiotic Usage by Utilising Gyssens Flow and The Success of Treatment in Negative Gram MDR Sepsis in Tertiary Hospital," Jurnal Penyakit Dalam Indonesia: Vol. 7: Iss. 4, Article 6.
DOI: 10.7454/jpdi.v7i4.468
Available at: https://scholarhub.ui.ac.id/jpdi/vol7/iss4/6